The analysis of the drug–targets based on the topological properties in the human protein–protein interaction network

References

• Barabasi AL, Oltvai ZN. (2004). Network biology: understanding the cell’s functional organization. Nat Rev Genet, 5, 101–113.
   PubMed Web of Science ®Google Scholar
• Blake JA, Bult CJ. (2006). Beyond the data deluge: data integration and bio-ontologies. J Biomed Inform, 39, 314–320.
   PubMed Web of Science ®Google Scholar
• Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M, Oughtred R, Lackner DH, Bähler J, Wood V, Dolinski K, Tyers M. (2008). The BioGRID Interaction Database: 2008 update. Nucleic Acids Res, 36, D637–D640.
   PubMed Web of Science ®Google Scholar
• Butte AJ, Kohane IS. (2006). Creation and implications of a phenome-genome network. Nat Biotechnol, 24, 55–62.
   PubMed Web of Science ®Google Scholar
• Goldberg DS, Roth FP. (2003). Assessing experimentally derived interactions in a small world. Proc Natl Acad Sci USA, 100, 4372–4376.
   PubMed Web of Science ®Google Scholar
• Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. (2005). Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res, 33, D514–D517.
   PubMed Web of Science ®Google Scholar
• Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M. (2004). Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature, 430, 88–93.
   PubMed Web of Science ®Google Scholar
• Hermeking H. (2003). The MYC oncogene as a cancer drug target. Curr Cancer Drug Targets, 3, 163–175.
   PubMed Web of Science ®Google Scholar
• Hopkins AL, Groom CR. (2002). The druggable genome. Nat Rev Drug Discov, 1, 727–730.
   PubMed Web of Science ®Google Scholar
• James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. (2007). BRCA1, a potential predictive biomarker in the treatment of breast cancer. Oncologist, 12, 142–150.
   Google Scholar
• Jiang T, Keating AE. (2005). AVID: an integrative framework for discovering functional relationships among proteins. BMC Bioinformatics, 6, 136.
   PubMedGoogle Scholar
• Jonsson PF, Bates PA. (2006). Global topological features of cancer proteins in the human interactome. Bioinformatics, 22, 2291–2297.
   PubMed Web of Science ®Google Scholar
• Loging W, Harland L, Williams-Jones B. (2007). High-throughput electronic biology: mining information for drug discovery. Nat Rev Drug Discov, 6, 220–230.
   PubMed Web of Science ®Google Scholar
• Ma X, Tarone AM, Li W. (2008). Mapping genetically compensatory pathways from synthetic lethal interactions in yeast. PLoS ONE, 3, e1922.
   PubMedGoogle Scholar
• Maloney A, Workman P. (2002). HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther, 2, 3–24.
   PubMed Web of Science ®Google Scholar
• Mete M, Tang F, Xu X, Yuruk N. (2008). A structural approach for finding functional modules from large biological networks. BMC Bioinformatics, 9(Suppl. 9), S19.
   PubMedGoogle Scholar
• Nahi H, Selivanova G, Lehmann S, Möllgård L, Bengtzen S, Concha H, Svensson A, Wiman KG, Merup M, Paul C. (2008). Mutated and non-mutated TP53 as targets in the treatment of leukaemia. Br J Haematol, 141, 445–453.
   PubMed Web of Science ®Google Scholar
• Plewczynski D, Rychlewski L. (2009). Meta-basic estimates the size of druggable human genome. J Mol Model, 15, 695–699.
   PubMed Web of Science ®Google Scholar
• Potts SJ, Edwards DJ, Hoffman R. (2005). Challenges of target/compound data integration from disease to chemistry: a case study of dihydrofolate reductase inhibitors. Curr Drug Discov Technol, 2, 75–87.
   PubMedGoogle Scholar
• Rakotomamonjy A. (2004). Optimizing area under ROC curve with SVMs. In Proceedings of the Workshop on ROC Analysis in Artificial Intelligence, pp. 71–80.
   Google Scholar
• Schwikowski B, Uetz P, Fields S. (2000). A network of protein-protein interactions in yeast. Nat Biotechnol, 18, 1257–1261.
   PubMed Web of Science ®Google Scholar
• Tu Z, Wang L, Xu M, Zhou X, Chen T, Sun F. (2006). Further understanding human disease genes by comparing with housekeeping genes and other genes. BMC Genomics, 7, 31.
   PubMedGoogle Scholar
• Turkson J. (2004). STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets, 8, 409–422.
   PubMed Web of Science ®Google Scholar
• Ulitsky I, Shamir R. (2007). Pathway redundancy and protein essentiality revealed in the Saccharomyces cerevisiae interaction networks. Mol Syst Biol, 3, 104.
   PubMedGoogle Scholar
• Vazquez A, Flammini A, Maritan A, Vespignani A. (2003). Global protein function prediction from protein-protein interaction networks. Nat Biotechnol, 21, 697–700.
   PubMed Web of Science ®Google Scholar
• Wachi S, Yoneda K, Wu R. (2005). Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics, 21, 4205–4208.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC. (2007). Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology, 132, 1066–1076.
   PubMed Web of Science ®Google Scholar
• Watts DJ, Strogatz SH. (1998). Collective dynamics of “small-world” networks. Nature, 393, 440–442.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res, 36, D901–906.
   PubMed Web of Science ®Google Scholar
• Wuchty S, Almaas E. (2005a). Peeling the yeast protein network. Proteomics, 5, 444–449.
   PubMed Web of Science ®Google Scholar
• Wuchty S, Almaas E. (2005b). Evolutionary cores of domain co- occurrence networks. BMC Evol Biol, 5, 24.
   PubMedGoogle Scholar
• Yang L, Vondriska TM, Han Z, Maclellan WR, Weiss JN, Qu Z. (2008). Deducing topology of protein-protein interaction networks from experimentally measured sub-networks. BMC Bioinformatics, 9, 301.
   PubMedGoogle Scholar
• Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. (2007). Drug-target network. Nat Biotechnol, 25, 1119–1126.
   PubMed Web of Science ®Google Scholar
• Zhu M, Gao L, Guo Z, Li Y, Wang D, Wang J, Wang C. (2007). Globally predicting protein functions based on co-expressed protein-protein interaction networks and ontology taxonomy similarities. Gene, 391, 113–119.
   PubMed Web of Science ®Google Scholar